Keywords: amgen, kineret, cleared, first, market, interleukin-1, receptor

Amgen's Kineret cleared in first market

Article | 16 November 2001

Print This

Amgen's interleukin-1 receptor antagonist Kineret (anakinra) has beenapproved in its first market, the USA, for the reduction in signs and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in